MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Assets | ₹11,883 Cr | ₹9,686 Cr | ₹9,108 Cr | ₹6,324 Cr | ₹5,025 Cr |
What is the latest Total Assets ratio of MANKIND PHARMA ?
Year | Total Assets |
---|---|
Mar2024 | ₹11,883 Cr |
Mar2023 | ₹9,686 Cr |
Mar2022 | ₹9,108 Cr |
Mar2021 | ₹6,324 Cr |
Mar2020 | ₹5,025 Cr |
How is Total Assets of MANKIND PHARMA Trending?
Years | Total Assets | % Change | |
---|---|---|---|
Mar2024 | ₹11,883 Cr | 22.68 | |
Mar2023 | ₹9,686 Cr | 6.34 | |
Mar2022 | ₹9,108 Cr | 44.04 | |
Mar2021 | ₹6,324 Cr | 25.83 | |
Mar2020 | ₹5,025 Cr | - |
Compare Total Assets of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹98,144.2 Cr | 0.7% | -6.7% | 10.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,768.0 Cr | 0.5% | -0.5% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,468.0 Cr | 1.3% | 10.7% | 49.3% | Stock Analytics | |
CIPLA | ₹121,326.0 Cr | 2.2% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,757.0 Cr | 4.7% | 11.9% | 14.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,345.0 Cr | 2% | -0.8% | 15.7% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 0.7% |
-6.7% |
10.3% |
SENSEX | 1.9% |
0.1% |
10.9% |
You may also like the below Video Courses